posts tagged as Drug pricing
BDO Knows Healthcare Spring 2016 Newsletter
In the Spring 2016 edition of the BDO Knows Healthcare newsletter, we focus on the impact of changing reimbursements across the healthcare spectrum: on investors, providers and pharmaceutical companies.
By William Bithoney | November 10, 2015
Pharmacy Benefits Managers: A Driving Force for Deals
Walgreens’ recent announcement to acquire Rite Aid generated plenty of buzz, with analysts suggesting that the deal was really about pharmacy benefits managers (PBMs). Controlling drug costs has become a major focus for providers...
By William Bithoney | October 02, 2015
340B Program Guidance Finally Sets Sail
For several years, hospital administrators and clinicians have been anxiously awaiting proposed new “mega” regulations affecting the federal 340B drug program. After hitting a bump in the road earlier this year, the Health...
The 340B “Mega-Reg” Is Gone, But Not Forgotten
Parting is such sweet sorrow. So says William Shakespeare in Romeo and Juliet. The Health Resources and Services Administration (HRSA) would no doubt agree with old Bill when it comes to the 340B Program’s proposed &ldquo...